POULTRY IMMUNOGENETICS - WHICH WAY DO WE GO

被引:13
|
作者
LAMONT, SJ
机构
[1] Department of Animal Science, Iowa State University, Ames
关键词
MAJOR HISTOCOMPATIBILITY COMPLEX; IMMUNE RESPONSE; GENETICS; SELECTION; DISEASE;
D O I
10.3382/ps.0731044
中图分类号
S8 [畜牧、 动物医学、狩猎、蚕、蜂];
学科分类号
0905 ;
摘要
A major goal in poultry immunogenetics is the enhancement of innate immunoresponsiveness and resistance to disease. This may be pursued by studying either single genes or polygenic traits. The MHC is perhaps the best-characterized family of host genes that modulates response to a variety of antigens and pathogenic challenges. The association of different MHC alleles with disease resistance has been known for decades. But only recently has analysis at the DNA level opened new avenues of understanding and new opportunities for application of genetic variation in the MHC with immunoresponsiveness. An alternate approach to molecular analysis is selection for a desired phenotype controlled by polygenes. Several studies have illustrated the successful alteration of immunoresponsiveness by genetic selection for antibody production. Recently, a selection program based upon multiple traits of immune response was conducted. Results of this project demonstrated that selection on multiple immune-response traits altered immunophysiology, MHC allelic frequencies, and disease resistance. Several areas for future pursuits in poultry immunogenetics research are proposed.
引用
收藏
页码:1044 / 1048
页数:5
相关论文
共 50 条
  • [1] Which Way Do We Go?
    Kirkpatrick, John S.
    JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 2017, 99 (12):
  • [2] Which way do we go?
    Bushaw, William J.
    Lopez, Shane J.
    PHI DELTA KAPPAN, 2013, 95 (01) : 9 - 9
  • [3] Which Way Do We Go?
    Chua, Amy
    NEW YORK TIMES BOOK REVIEW, 2009, : 27 - 27
  • [4] Which way do we go?: Leading for diversity in the new frontier
    Tatum, BD
    JOURNAL OF NEGRO EDUCATION, 1999, 68 (04): : 550 - 554
  • [5] Challenges to environmental toxicology and epidemiology:: where do we stand and which way do we go?
    Pesch, B
    Brüning, T
    Frentzel-Beyme, R
    Johnen, G
    Harth, V
    Hoffmann, W
    Ko, Y
    Ranft, U
    Traugott, UG
    Thier, R
    Taeger, D
    Bolt, HM
    TOXICOLOGY LETTERS, 2004, 151 (01) : 255 - 265
  • [6] WHICH WAY SHOULD WE GO
    WIANT, C
    JOURNAL OF ENVIRONMENTAL HEALTH, 1992, 55 (03) : 43 - 43
  • [7] Which way did we go?
    May, M
    AMERICAN SCIENTIST, 1997, 85 (06) : 521 - 521
  • [8] Which Way Do We Go? Complex Interactions in Atopic Dermatitis Pathogenesis
    Patrick, Garrett J.
    Archer, Nathan K.
    Miller, Lloyd S.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2021, 141 (02) : 274 - 284
  • [9] Aligning quality for populations and patients: Do we know which way to go?
    Lubetkin, EI
    Sofaer, S
    Gold, MR
    Berger, ML
    Murray, JF
    Teutsch, SM
    AMERICAN JOURNAL OF PUBLIC HEALTH, 2003, 93 (03) : 406 - 411
  • [10] HTA: WHERE ARE WE AND WHICH WAY WILL WE GO?
    del Llano-Senaris, J. E.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2014, 115 : 6 - 6